NDC 62175-452 – Buprenorphine and Naloxone

Buprenorphine 2 mg/1; Naloxone .5 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC62175-452

Product details

Brand name
Buprenorphine and Naloxone
Generic name
Buprenorphine and Naloxone
Labeler
Lannett Company, Inc.
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA205022
Marketed since
September 19, 2016
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine and Naloxone →

Package NDC codes (1)

Package NDCDescriptionSince
62175-452-3230 TABLET in 1 BOTTLE (62175-452-32)Sep 19, 2016

Other Buprenorphine and Naloxone products